Document:

EX-10.3

 

EXHIBIT 10.3

EMPLOYMENT AGREEMENT

          THIS EMPLOYMENT AGREEMENT (the “Agreement”), dated September 12, 2006, shall
become effective upon the consummation of the mergers contemplated by the Agreement and Plan of
Merger referenced below (the “Effective Date”), is entered into by and between HEALTH CARE
REIT, INC., a Delaware corporation (the “Corporation”), and DANIEL R. LOFTUS (the
“Executive”).

          WHEREAS, the Executive serves as an executive officer of Windrose Medical Properties Trust
(the “Trust”), which is the sole general partner of Windrose Medical Properties L.P. (the
“LP”);

          WHEREAS, the Corporation and certain of its subsidiaries, simultaneously with the execution of
this Agreement, are entering into an Agreement and Plan of Merger with the Trust and the LP
(“Merger Agreement”) providing for the merger of the Trust into a wholly owned subsidiary
of the Corporation and the merger of a wholly owned subsidiary of the Corporation into the LP
(collectively, the “Mergers”); and

          WHEREAS, effective as of the Effective Date, the Corporation wishes to assure itself of the
services of the Executive for the period provided in this Agreement, and the Executive is willing
to serve in the employ of the Corporation for such period upon the terms and conditions set forth
in this Agreement.

          NOW THEREFORE, in consideration of the mutual covenants herein contained, the parties,
intending to be legally bound, agree as follows:

     1. EMPLOYMENT.

          The Corporation employs the Executive as the Executive Vice President — Medical Properties
Division (the “Division”) of the Corporation and Senior Vice President of the Corporation
upon the terms and conditions herein contained, and the Executive agrees to accept such employment
and to serve in such positions, and to perform the duties and functions customarily performed by
such officer in a publicly traded corporation. The Executive’s responsibilities will generally
include management of the business development process from the Division, internal legal support
for the Division, including HADC, and support of the President of the Division in all aspects of
operations. In such capacity, the Executive shall report to the President of the Division, and
shall have such powers and responsibilities consistent with his position as the President of the
Division, the President of the Corporation, the Chief Executive Officer of the Corporation or the
Chairman or Vice Chairman of the Corporation may assign to him.

          Throughout the Term of this Agreement, the Executive shall devote his best efforts and all of
his business time and services to the business and affairs of the Corporation.

 

 

     2. TERM OF AGREEMENT.

          The term of employment under this Agreement shall be for two years beginning on the Effective
Date and expiring on the day before the second anniversary of the Effective Date (“Term”).
The Term will automatically be extended for successive two-year periods unless either the
Corporation or the Executive gives at least six months’ written notice of termination before the
end of the then-current Term. As used in this Agreement, “Term” means only the then-current
two-year period.

          Notwithstanding the foregoing, the Corporation shall be entitled to terminate this Agreement
immediately, subject to a continuing obligation to make any payments required under Section 5
below, if the Executive (i) becomes disabled as described in Section 5(b), (ii) is terminated for
Cause, as defined in Section 5(c), or (iii) voluntarily terminates his employment before the Term
expires, as described in Section 5(d).

     3. SALARY AND BONUS.

          The Executive shall receive a retention bonus on the later of (x) the Effective Date or (y)
January 2, 2007 of (i) $266,750, plus (ii) shares of the Corporation’s common stock having a value
of $200,000 (“Initial Stock Award”) based on the closing price of the Corporation’s common
stock as of the date prior to the date of the Effective Date. All such shares shall be fully
vested as of the Effective Date and shall be fully registered under state and federal securities
laws and approved for listing on the New York Stock Exchange so as to be freely tradable by the
Executive at the time of receipt.

          The Executive shall receive a Base Salary (“Base Salary”) during the Term as follows,
payable in equal semi-monthly installments in accordance with the Corporation’s customary payroll
practices:

	 	 	 	 	 
	Year	 	Base Salary
	Year 1

	 	$	260,000	 
	 
	 	 	 	 
	Year 2

	 	$	267,800	 

          The Executive shall also be eligible to receive a bonus (“Performance Bonus”) from the
Corporation each fiscal year during the Term. The amount of the Performance Bonus shall be
determined by the Compensation Committee of the Corporation’s Board, using such performance
measures as the Compensation Committee deems to be appropriate; provided, however, that the target
amount of such bonus for 2007 and 2008 shall be between 25% and 50% of the Executive’s Base Salary.

          Notwithstanding anything herein to the contrary and in addition to any other payment described
herein, if not paid by the Trust or the LP prior to the Effective Date, the Corporation shall pay
to the Executive, no later than the later of the Effective Date or March 15, 2007, the cash amount
of $94,000, representing the full amount of the Executive’s bonus for 2006 from the Trust and the
LP in accordance with the bonus criteria for the Executive in place for the 2006 fiscal year.

2

 

     4. ADDITIONAL COMPENSATION AND BENEFITS.

          The Executive shall receive the following additional compensation and welfare and fringe
benefits:

          (a) Stock Options and Other Long-Term Incentives. During the Term, any stock options,
restricted stock or other awards under the Corporation’s 2005 Long-Term Incentive Plan shall be at
the discretion of the Compensation Committee of the Corporation’s Board; provided, however, that
the target Long-Term Incentive Range shall be between 25% and 70% of the Executive’s Base Salary
and Performance Bonus.

          (b) Health Insurance. The Corporation shall provide the Executive and his dependents
with health insurance, life insurance and disability coverage on terms no less favorable than that
from time to time made available to other key employees.

          (c) Vacation. The Executive shall be entitled to up to three weeks of vacation during
each year during the Term.

          (d) Business Expenses. The Corporation shall reimburse the Executive for all
reasonable expenses he incurs in promoting the Corporation’s business, including expenses for
travel and similar items, upon presentation by the Executive from time to time of an itemized
account of such expenditures.

          (e) Other Benefits. In addition to the benefits provided pursuant to this Section 4,
the Executive shall be eligible to participate in such other executive compensation and retirement
plans of the Corporation as are applicable generally to other executive officers, and in such
welfare benefit plans, programs, practices and policies of the Corporation as are generally
applicable to other executive officers, unless such participation would duplicate, directly or
indirectly, benefits already accorded to the Executive.

     5. PAYMENTS UPON TERMINATION.

          In addition to payment of the amount described in Section 5(f):

          (a) Involuntary Termination. If the Executive’s employment is terminated by the
Corporation during the Term, the Executive shall be entitled to receive his Base Salary accrued
through the date of termination, any accrued but unpaid vacation pay, plus any Performance Bonus
earned but unpaid with respect to fiscal years or other periods (including any partial fiscal
years) preceding the termination date. The Executive shall also receive any nonforfeitable
benefits payable to him under the terms of any deferred compensation, incentive or other benefit
plan maintained by the Corporation, payable in accordance with the terms of the applicable plan.

          If the termination is not a termination for Cause, as described in Section 5(c), a voluntary
termination by the Executive as described in Section 5(d), or a result of the Executive’s death or
disability, then the Corporation shall also be obligated to make a series of monthly severance
payments to the Executive for each month during the remainder of the Term. Each monthly payment
shall be equal to the Executive’s monthly Base Salary for the remainder

3

 

of the Term. If the Executive obtains a replacement position with any new employer (including a
position as an officer, employee, consultant or agent, or self-employment as a partner or sole
proprietor), the payments shall be reduced by all amounts the Executive receives as compensation
for services performed during such period. The Executive shall be under no duty to mitigate the
amounts owed to him under this Section 5(a) by seeking such a replacement position.

          In addition, if the termination is not a termination for Cause as described in Section 5(c), a
voluntary termination by the Executive as described in Section 5(d), or a result of the Executive’s
death or disability, then:

          (i) the Initial Stock Award and any stock options, restricted stock or other
awards granted to the Executive under the Corporation’s 2005 Long-Term Incentive
Plan shall become fully vested and, in the case of stock options, exercisable in
full; and

          (ii) the Executive shall be provided continued coverage at the Corporation’s
expense under any life, health and disability insurance programs maintained by the
Corporation in which the Executive participated at the time of his termination for
the remainder of the Term (but not less than six months), or until, if earlier, the
date the Executive obtains comparable coverage under benefit plans maintained by a
new employer.

          (b) Disability. The Corporation shall be entitled to terminate this Agreement, if the
Board determines that the Executive has been unable to attend to his duties for at least 90 days
because of a medically diagnosable physical or mental condition, and has received a written opinion
from a physician acceptable to the Board that such condition prevents the Executive from resuming
full performance of his duties and is likely to continue for an indefinite period. Upon such
termination, the Executive shall be entitled to receive his Base Salary accrued through the date of
termination, any accrued but unpaid vacation pay, plus any Performance Bonus earned but unpaid with
respect to fiscal years or other periods (including any partial fiscal years) preceding the
termination date. In addition, the Initial Stock Award shall become fully vested and the
Corporation shall make a series of monthly disability payments to Executive, each equal to his
monthly Base Salary during the remainder of the Term. Payment of such disability benefit shall
commence with the month following the date of the termination by reason of permanent disability and
continue each month for the remainder of the Term, but shall terminate at an earlier date if the
Executive returns to active employment, either with the Corporation or otherwise. Any amounts
payable under this Section 5(b) shall be reduced by any amounts paid to the Executive under any
long-term disability plan or other disability program or disability insurance policies maintained
or provided by the Corporation.

          (c) Termination for Cause. If the Executive’s employment is terminated by the
Corporation for Cause, the amount the Executive shall be entitled to receive from the Corporation
shall be limited to his Base Salary accrued through the date of termination, any accrued but unpaid
vacation pay, plus any Performance Bonus earned but unpaid with respect to the fiscal year of the
Corporation most recently ended, and any nonforfeitable benefits payable to

4

 

the Executive under the terms of deferred compensation, incentive or other benefit plans maintained
by the Corporation.

          For purposes of this Agreement, the term “Cause” shall be limited to (i) action by the
Executive involving willful disloyalty to the Corporation, such as embezzlement, fraud,
misappropriation of corporate assets or a breach of the covenants set forth in Sections 7 and 8
below; or (ii) the Executive being convicted of a felony; or (iii) the Executive being convicted of
any lesser crime or offense committed in connection with the performance of his duties hereunder or
involving moral turpitude; or (iv) the intentional and willful failure by the Executive to
substantially perform his duties hereunder as directed by the Corporation’s Chairman, Vice
Chairman, Chief Executive Officer or President or the President of the Division (other than any
such failure resulting from the Executive’s incapacity due to physical or mental disability); or
(v) the Executive’s failure to obtain minimum performance goals to be determined by the
Compensation Committee of the Corporation’s Board, in its discretion. Notwithstanding the
foregoing, willful disloyalty shall not be deemed to include the refusal of the Executive to engage
in any unlawful or unethical conduct or conduct in violation of the Corporation’s policies.

          (d) Voluntary Termination by the Executive. If the Executive resigns or otherwise
voluntarily terminates his employment before the end of the Term, the amount the Executive shall be
entitled to receive from the Corporation shall be limited to his Base Salary accrued through the
date of termination, any accrued but unpaid vacation pay, plus any Performance Bonus earned but
unpaid with respect to any fiscal years or other periods (including any partial fiscal years)
preceding the termination date, and any nonforfeitable benefits payable to the Executive under the
terms of any deferred compensation, incentive or other benefit plans of the Corporation.

          For purposes of this Section 5(d), a resignation by the Executive shall not be deemed to be
voluntary and shall be deemed to be involuntary under Section 5(a) if the Executive is (i) assigned
to a position other than Executive Vice President of the Division and Senior Vice President of the
Corporation (other than for Cause or by reason of permanent disability); (ii) assigned duties
materially inconsistent with such position; (iii) directed to report to anyone other than the
President of the Division or the President, Vice Chairman, Chief Executive Officer or Chairman of
the Corporation; (iv) asked by the Corporation to locate in any place other than Nashville,
Tennessee or Indianapolis, Indiana; or (v) directed to engage in any unlawful or unethical conduct
or conduct in violation of the Corporation’s policies.

          (e) Death. If the Executive dies during the Term, the Corporation shall pay to the
Executive’s estate a lump sum payment equal to the sum of the Executive’s Base Salary accrued
through the date of death, any accrued but unpaid vacation pay, plus any Performance Bonus earned
but unpaid with respect to fiscal years or other periods (including any partial fiscal years)
preceding the date of death. In addition, the Corporation shall pay to the Executive’s surviving
spouse (or such other beneficiary as the Executive may designate in writing) a lump sum payment
equal to the present value of the monthly Base Salary that would have been paid during the
remainder of the Term. Such present value shall be calculated using a discount rate equal to the
interest rate on 90-day Treasury bills, as reported in The Wall Street Journal (or similar
publication) for the date of death. In addition, the death benefits payable by reason of the

5

 

Executive’s death under any retirement, deferred compensation, life insurance or other employee
benefit plan maintained by the Corporation shall be paid to the beneficiary designated by the
Executive, and the stock options, restricted stock or other awards held by the Executive under the
Corporation’s stock plans shall become fully vested, and, in the case of stock options, exercisable
in full, in accordance with the terms of the applicable plan or plans.

          (f) Termination Payment. Notwithstanding anything herein to the contrary, in addition
to any other amounts payable to Executive under this Section 5, if the Executive’s employment
terminates or is terminated at any time during the first two-year Term for any reason (including,
but not limited to, a termination for Cause), if the Executive dies or is disabled during the first
two-year Term, or this Agreement is not renewed or extended, then the Corporation shall pay to the
Executive, or his surviving spouse or other beneficiary, a lump sum termination payment of $288,000
(“Termination Payment”), which payment shall be made on the last day of Executive’s
employment by the Corporation. The Termination Payment shall not be subject to offset, reduction
or credit under any other provision of this Agreement or under any other circumstances, except for
the reduction of such payment in this Agreement if renewed as set forth in the following sentence.
If the Executive’s employment is extended for an additional two-year Term after the expiration of
the Term of this Agreement, and thereafter the Executive’s employment is terminated at any time
during the second two-year Term for any reason, if Executive dies or is disabled during the second
two-year Term, or this Agreement is not renewed or extended at the end of the second two-year Term,
then the Corporation shall pay to the Executive an amount equal to one-half of the Termination
Payment, in addition to any other amounts otherwise payable to the Executive under any extended or
new agreement, which payment shall be made on the last day of the Executive’s employment by the
Corporation.

          (g) Section 409A. This Section 5(g) applies if any benefit or payment under this
Agreement that is payable on account of termination of the Executive’s employment is subject to
Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) and the
Executive is a “specified employee” (as defined in Section 409A of the Code). In that event, any
such benefit or payment that is payable on account of the Executive’s termination of employment
shall begin to be paid on the first day of the seventh month beginning after the Executive’s
termination of employment. The first payment of such benefit or payment shall include the amount
that would have been paid following the Executive’s termination of employment and on or before such
first payment but for the requirement of the preceding sentence.

          (h) Relocation Allowance. If the Corporation requests that the Executive relocate
from Indianapolis, Indiana to Nashville, Tennessee, the Corporation shall reimburse the Executive
for reasonable moving expenses.

     6. WITHHOLDING.

          The Corporation shall, to the extent permitted by law, have the right to withhold and deduct
from any payment hereunder any federal, state or local taxes of any kind required by law to be
withheld with respect to any such payment.

6

 

     7. PROTECTION OF CONFIDENTIAL INFORMATION.

          The Executive shall keep all confidential and proprietary information of the Corporation or
relating to its business confidential, and he will not (except with the Corporation’s prior written
consent), while in the employ of the Corporation or thereafter, disclose any such confidential
information to any person, firm, corporation, association or other entity, other than in
furtherance of his duties hereunder, and then only to those with a “need to know.” The Executive
shall not make use of any such confidential information for his own purposes or for the benefit of
any person, firm, corporation, association or other entity (except the Corporation) under any
circumstances during or after the term of his employment. The foregoing shall not apply to any
information which is already in the public domain, or is generally disclosed by the Corporation or
is otherwise in the public domain at the time of disclosure.

          The Executive recognizes that because his work for the Corporation may bring him into contact
with confidential and proprietary information of the Corporation, the restrictions of this Section
7 are required for the reasonable protection of the Corporation and its investments and for the
Corporation’s reliance on and confidence in the Executive.

     8. COVENANT NOT TO COMPETE.

          The Corporation and the Executive acknowledge and agree that as a former executive officer of
the Trust, the Executive has knowledge and experience in the business of the Trust and that the
limitations on the Executive’s activities described in this Section 8 are reasonable and
appropriate. The Executive shall not, either during the Term or during the period of two years
from the time the Executive’s employment under this Agreement (as the same may be extended) is
terminated for any reason, engage in any business activities on behalf of any enterprise which
competes with the Corporation in the business of the passive ownership of senior housing or health
care facilities, or passive investing in or lending to health care-related enterprises, including,
without limitation, medical office buildings, hospitals of any kind, independent living facilities,
assisted living facilities, skilled nursing facilities, inpatient rehabilitation facilities,
ambulatory surgery centers, active adult projects or any similar types of facilities or projects.
The Executive will be deemed to be engaged in such competitive business activities if he
participates in such a business enterprise as an employee, officer, director, trustee, executive,
agent, partner, proprietor or other participant; provided that the ownership of no more than 2% of
the stock of a publicly traded entity engaged in a competitive business shall not be deemed to be
engaging in competitive business activities. Notwithstanding the foregoing, nothing in this
section shall restrict the Executive from becoming associated with a private law firm.

          The Executive agrees that he shall not, for a period of two years from the time his employment
under this Agreement ceases (for whatever reason), solicit any employee or full-time executive of
the Corporation for the purposes of hiring or retaining such employee or executive.

          Notwithstanding the provisions of any other agreement between the Executive and the Trust, the
LP or any of their affiliates, the parties agree that the provisions of any such

7

 

other agreement that purport to restrict the business, employment or investment activities of the
Executive or impose confidentiality obligation on the Executive shall be null and void and of no
further force and effect as of the Effective Date and thereafter the provisions of Section 7 and
this Section 8 shall be the sole provisions relating to restriction on the business, employment or
business activities of the Executive or confidentiality obligations binding upon the Executive or
enforceable against the Executive by the Corporation or any of its subsidiaries or affiliates.

     9. INJUNCTIVE RELIEF.

          The Executive acknowledges and agrees that it would be difficult to fully compensate the
Corporation for damages resulting from the breach or threatened breach of the covenants set forth
in Sections 7 and 8 of this Agreement. Accordingly, the Corporation shall be entitled to temporary
and injunctive relief, including temporary restraining orders, preliminary injunctions and
permanent injunctions, to enforce such provisions in any action or proceeding instituted in the
United States District Court for the Northern District of Ohio or in any court in the State of Ohio
having subject matter jurisdiction. This provision with respect to injunctive relief shall not,
however, diminish the Corporation’s right to claim and recover damages.

          It is expressly understood and agreed that although the parties consider the restrictions
contained in this Agreement to be reasonable, if a court determines that the time or territory or
any other restriction contained in this Agreement is an unenforceable restriction on the activities
of the Executive, no such provision of this Agreement shall be rendered void but shall be deemed
amended to apply as to such maximum time and territory and to such extent as such court may
judicially determine or indicate to be reasonable.

     10. NOTICES.

          All notices or communications hereunder shall be in writing and sent certified or registered
mail, return receipt requested, postage prepaid, addressed as follows (or to such other address as
such party may designate in writing from time to time):

If to the Corporation:

Health Care REIT, Inc.

One SeaGate, Suite 1500

Toledo, Ohio 43604

Attention: Chief Executive Officer

If to the Executive:

Daniel R. Loftus

Windrose Medical Properties Trust

3502 Woodview Trace, Suite 210

Indianapolis, Indiana 46268

The actual date of receipt, as shown by the receipt therefor, shall determine the time at which
notice was given.

8

 

     11. SEPARABILITY.

          If any provision of this Agreement shall be declared to be invalid or unenforceable, in whole
or in part, such invalidity or unenforceability shall not affect the remaining provisions hereof,
which shall remain in full force and effect.

     12. ASSIGNMENT.

          This Agreement shall be binding upon and inure to the benefit of the heirs and representatives
of the Executive and the assigns and successors of the Corporation, but neither this Agreement nor
any rights hereunder shall be assignable or otherwise subject to hypothecation by the Executive.

     13. ENTIRE AGREEMENT.

          This Agreement represents the entire agreement of the parties and shall supersede any and all
previous contracts, arrangements or understandings between the Corporation, the LP or the Trust and
the Executive, including the Change of Control Severance Agreement dated on or about August 16,
2002 and the Confidentiality Agreement dated on or about August 16, 2002 among the Executive, the
Trust and the LP. This Agreement may be amended at any time by mutual written agreement of the
parties hereto.

     14. GOVERNING LAW.

          This Agreement shall be construed, interpreted and governed in accordance with the laws of the
State of Ohio, other than the conflict of laws provisions of such laws.

     15. SURVIVAL.

          Sections 5, 6, 7, 8, 9, 11, 13, 14 and 16 shall survive any expiration or termination of this
Agreement.

     16. EXCISE TAX INDEMNIFICATION.

          The Executive shall be entitled to a payment or payments under this Section 16 if any payment
or benefit provided under this Agreement or any other plan, agreement or arrangement with the
Corporation, the Trust, the LP or any of their affiliates constitutes an “excess parachute payment”
(as defined in Section 280G(b)(1) of the Code, but without regard to Section 280G(b)(2)(A)(ii) of
the Code) and the Executive incurs a liability under Section 4999 of the Code. The amount payable
to the Executive under this Section 16 shall be the amount required to indemnify the Executive and
hold him harmless from the application of Sections 280G and 4999 of the Code, together with any
interest or penalties related thereto, with respect to benefits, payments, accelerated
exercisability and vesting and other rights under this Agreement or otherwise, and any income,
employment, hospitalization, excise and other taxes and penalties attributable to the
indemnification payment. The benefit payable under this Section 16 shall be calculated and paid
not later than the date (or extended filing date) on which the tax return reflecting liability for
the excise tax under Section 4999 of the Code is required to be filed with the Internal Revenue
Service. To the extent that any other plan, agreement or arrangement

9

 

requires that the Executive be indemnified and held harmless from the application of Sections 280G
and 4999 of the Code, any such indemnification and the amount required to be paid to the Executive
under this Section 16 shall be coordinated so that such indemnification is paid only once and the
obligations of the Corporation, the Trust, the LP or any of their affiliates shall be satisfied to
the extent of any such other payment (and vice versa).

          The Executive and the Corporation agree that the application of Sections 280G and 4999 of the
Code may not be clear in all cases. The Executive agrees that the Company may take the position
that all or part of a payment or payments are not “excess parachute payments” (as defined above)
and do not result in liability under Section 4999 of the Code. The Executive agrees that his
individual tax returns will be prepared in a manner that is consistent with the Corporation’s
position on such matters if the Executive’s professional tax preparer concludes, in his or her
professional opinion, that the Corporation’s position is reasonable based on published rulings,
regulations and other authority. If the Executive’s individual income tax return is prepared in
accordance with the preceding sentence, i.e., in a manner consistent with the Corporation’s
position, then (in addition to any benefit payable under the preceding paragraph) the Corporation
shall indemnify the Executive, and hold him harmless, from any liability for tax, penalty, interest
or otherwise arising from the position stated on the Executive’s individual income tax return
related to the application of Section 280G or 4999 of the Code to payment from the Corporation, the
Trust, the LP or any of their affiliates. If the Executive’s professional tax preparer does not
agree that the Corporation’s position is reasonable based on published rulings, regulations and
other authority, then the Executive’s individual tax return will reflect any liability under
Section 4999 of the Code that such professional tax preparer determines is appropriate and the
Corporation shall indemnify the Executive and hold him harmless in accordance with the preceding
paragraph.

10

 

          IN WITNESS WHEREOF, the Corporation has caused this Agreement to be duly executed, and the
Executive has hereunto set his hand, as of the day and year first above written.

	 	 	 	 	 	 	 
	Attest:	 	 	 	HEALTH CARE REIT, INC.
	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	/s/ Erin C. Ibele

	 	 	 	By:
	 	/s/ George L. Chapman
	 

	 	 	 	 	 	 
	 

	 	 	 	 	 	Chief Executive Officer
	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	Witness:	 	 	 	EXECUTIVE:
	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	/s/ Charles W. Hiller

	 	 	 	By:
	 	/s/ Daniel R. Loftus
	 

	 	 	 	 	 	 
	 

	 	 	 	 	 	Daniel R. Loftus

11EX-10.4

 

    Exhibit 10.4

 

    SUPPORT
    AGREEMENT

 

    SUPPORT AGREEMENT, dated as of September 12, 2006 (this
    “Agreement”), by the undersigned beneficial
    interest holder (the “Shareholder”) of Windrose
    Medical Properties Trust, a Maryland real estate investment
    trust (the “Company”), for the benefit of
    Health Care REIT, Inc., a Delaware corporation
    (“Parent”).

 

    RECITALS

 

    WHEREAS, Parent, Heat Merger Sub, LLC, a Delaware limited
    liability company and a wholly-owned subsidiary of Parent
    (“Merger Sub”), Heat OP Merger Sub, L.P., a
    Virginia limited partnership and a wholly-owned subsidiary of
    Parent (“OP Merger Sub”), the Company and
    Windrose Medical Properties, L.P., a Virginia limited
    partnership and the operating limited partnership of the Company
    (“Company OP”), are entering into the Agreement
    and Plan of Merger, dated as of September 12, 2006 (the
    “Merger Agreement”), which provides for, among
    other things, the merger of the Company with and into Merger Sub;

 

    WHEREAS, the Shareholder owns that number of common shares of
    beneficial interest, par value $0.01 per share, of the
    Company (“Company Common Shares”), appearing on
    the signature page hereof (such Company Common Shares, together
    with any other Company Common Shares or other shares of
    beneficial interest or voting securities of the Company
    beneficially owned as of the date hereof or acquired by such
    Shareholder after the date hereof and during the term of this
    Agreement, being collectively referred to herein as the
    “Subject Shares”);

 

    WHEREAS, the Shareholder is a limited partner of Company OP and
    owns that number of units of partnership interest of Company OP
    (“Company OP Units”) appearing on the signature
    page hereof (such Company OP Units, together with any other
    Company OP Units or other units of partnership interest of
    Company OP beneficially owned as of the date hereof or acquired
    by such Shareholder after the date hereof and during the term of
    this Agreement, being collectively referred to herein as the
    “Subject Units”); and

 

    WHEREAS, as a condition to their willingness to enter into the
    Merger Agreement, Parent, Merger Sub and OP Merger Sub have
    required that the Shareholder agree, and in order to induce
    Parent, Merger Sub and OP Merger Sub to enter into the Merger
    Agreement the Shareholder has agreed, to enter into this
    Agreement.

 

    NOW, THEREFORE, in consideration of the promises and the mutual
    covenants and agreements set forth herein, the Shareholder
    agrees as follows:

 

    1. Capitalized Terms.   Capitalized
    terms used in this Agreement that are not defined herein shall
    have the meanings set forth in the Merger Agreement.

 

    2. Covenants of Shareholder.  
    Until the termination of this Agreement in accordance with
    Section 5:

 

    (a) The Shareholder shall attend the Company Shareholders
    Meeting, in person or by proxy, and at the Company Shareholders
    Meeting (or at any adjournment thereof) or in any other
    circumstances upon which a vote, consent or other approval with
    respect to the Merger and the Merger Agreement is sought, the
    Shareholder shall vote (or cause to be voted) the Subject Shares
    in favor of the Merger, the adoption of the Merger Agreement and
    the approval of the terms thereof.

 

    (b) At any meeting of Shareholders of the Company or at any
    adjournment thereof or in any other circumstances upon which the
    Shareholder’s vote, consent or other approval is sought,
    the Shareholder shall vote (or cause to be voted) the Subject
    Shares against (i) any merger agreement or merger (other
    than the Merger Agreement and the Merger), consolidation,
    combination, sale of substantial assets, reorganization,
    recapitalization, dissolution, liquidation or winding up of or
    by the Company or any Company Subsidiary or any other
    Acquisition Proposal or (ii) any action or agreement
    (including any amendment of the Company’s Amended and
    Restated Declaration of Trust or Amended and Restated Bylaws or
    other proposal or transaction involving the Company or any
    Company Subsidiary) that would (A) result in a breach of
    any covenant, representation or warranty or any other obligation
    or agreement under the Merger Agreement, (B) in any manner
    impede, interfere with, delay, discourage, postpone,

 

    frustrate, prevent, nullify or adversely affect the Merger, the
    Merger Agreement or any of the other transactions contemplated
    by the Merger Agreement or (C) change in any manner the
    voting rights of any class of beneficial interests of the
    Company. The Shareholder further agrees not to commit or agree
    to take any action inconsistent with the foregoing.

 

    (c) The Shareholder agrees not to (i) sell, transfer,
    pledge, assign or otherwise dispose of (including by gift)
    (collectively, “Transfer”), or enter into any
    contract, option or other arrangement (including any
    profit-sharing arrangement) with respect to the Transfer of the
    Subject Shares or Subject Units to any person or (ii) enter
    into any voting arrangement, whether by proxy, voting agreement
    or otherwise, in relation to the Subject Shares or Subject
    Units, and agrees not to commit or agree to take any of the
    foregoing actions.

 

    (d) The Shareholder agrees to promptly notify Parent in
    writing of the nature and amount of any acquisition by such
    Shareholder of any voting securities of the Company or any
    Company OP Units acquired by such Shareholder hereafter.

 

    3. Representations and
    Warranties.   The Shareholder represents and
    warrants to Parent as follows:

 

    (a) The Shareholder has the legal right, power and capacity
    to execute, deliver and perform this Agreement.

 

    (b) The Shareholder is the record and beneficial owner of,
    and has good and marketable title to, the Subject Shares (other
    than Subject Shares shown on the signature page hereto as being
    owned subject to restriction or forfeiture) and the Subject
    Units. The Shareholder does not own, of record or beneficially,
    any shares of beneficial interest of the Company other than the
    Subject Shares or the Subject Units. The Shareholder has the
    sole right to vote, and the sole power of disposition with
    respect to, the Subject Shares (other than Subject Shares shown
    on the signature page hereto as being owned subject to
    restriction or forfeiture) and the Subject Units, and none of
    the Subject Shares or Subject Units is subject to any voting
    trust, proxy or other agreement, arrangement or restriction with
    respect to the voting or disposition of such Subject Shares or
    Subject Units, except as contemplated by this Agreement.

 

    (c) This Agreement has been duly executed and delivered by
    the Shareholder and, assuming the due authorization, execution
    and delivery of this Agreement by Parent, this Agreement
    constitutes the valid and binding agreement of the Shareholder
    enforceable against the Shareholder in accordance with its terms.

 

    4. Grant of Irrevocable Proxy; Appointment of
    Proxy.   Until the termination of this
    Agreement in accordance with Section 5:

 

    (a) The Shareholder hereby severally irrevocably grants to,
    and appoints, George L. Chapman or William C. Ballard, Jr.,
    in their respective capacities as designees of the Company or
    other designees of the Company so designated, and each of them
    individually, or any of them, the Shareholder’s proxy and
    attorney-in-fact
    (with full power of substitution), for and in the name, place
    and stead of the Shareholder, to vote all of the Subject Shares
    owned of record by the Shareholder in accordance with
    Section 1(a) and Section 1(b) of this Agreement.

 

    (b) The Shareholder represents that any proxies heretofore
    given in respect of the Subject Shares are not irrevocable and
    that all such proxies are hereby revoked.

 

    (c) The Shareholder understands and acknowledges that
    Parent, Merger Sub and OP Merger Sub are entering into the
    Merger Agreement in reliance upon the Shareholder’s
    execution and delivery of this Agreement. The Shareholder hereby
    affirms that the irrevocable proxy set forth in this
    Section 3 is given in connection with the execution of the
    Merger Agreement and that such irrevocable proxy is given to
    secure the performance of the duties of the Shareholder under
    this Agreement. The Shareholder hereby further affirms that the
    irrevocable proxy is coupled with an interest and may under no
    circumstance be revoked. The Shareholder hereby ratifies and
    confirms all that such irrevocable proxy may lawfully do or
    cause to be done by virtue hereof.

    

    2

 

    5. Termination.   The obligations
    of the Shareholder hereunder shall terminate upon the earlier to
    occur of (i) the termination of the Merger Agreement
    pursuant to Section 9.1 thereof and (ii) the Effective
    Time.

 

    6. Successors, Assigns and Transferees
    Bound.   Any successor, assignee or transferee
    (including a successor, assignee or transferee as a result of
    the death of the Shareholder, such as an executor or heir) shall
    be bound by the terms hereof, and the Shareholder shall take any
    and all actions necessary to obtain the written confirmation
    from such successor, assignee or transferee that it is bound by
    the terms hereof.

 

    7. Remedies.   The Shareholder
    acknowledges that money damages would be both incalculable and
    an insufficient remedy for any breach of this Agreement by it,
    and that any such breach would cause Parent irreparable harm.
    Accordingly, the Shareholder agrees that in the event of any
    breach or threatened breach of this Agreement, Parent, in
    addition to any other remedies at law or in equity it may have,
    shall be entitled, without the requirement of posting a bond or
    other security, to equitable relief, including injunctive relief
    and specific performance.

 

    8. Severability.   The invalidity
    or unenforceability of any provision of this Agreement in any
    jurisdiction shall not affect the validity or enforceability of
    any other provision of this Agreement in such jurisdiction, or
    the validity or enforceability of any provision of this
    Agreement in any other jurisdiction.

 

    9. Amendment.   This Agreement may
    be amended only by means of a written instrument executed and
    delivered by both the Shareholder and Parent.

 

    10. Jurisdiction.   Each party
    hereby irrevocably submits to the exclusive jurisdiction of the
    courts of the State of Delaware in any action, suit or
    proceeding arising in connection with this Agreement, and agrees
    that any such action, suit or proceeding shall be brought only
    in such courts (and waives any objection based on forum non
    conveniens or any other objection to venue therein). Each
    party hereto waives any right to a trial by jury in connection
    with any such action, suit or proceeding.

 

    11. Governing Law.   Except to the
    extent that Entity Law is mandatorily applicable to the Merger,
    this Agreement shall be governed by, and construed in accordance
    with, the laws of the State of Delaware, regardless of the laws
    that might otherwise govern under applicable principles of
    conflicts of laws thereof.

 

    12. Notice.   All notices,
    requests, demands and other communications hereunder shall be
    deemed to have been duly given and made if in writing and if
    served by personal delivery upon the party for whom it is
    intended or if sent by telex or telecopier (and also confirmed
    in writing) to the person at the address set forth below, or
    such other address as may be designated in writing hereafter, in
    the same manner, by such person:

 

			
	 	    (a) 
	
    if to Parent, to:

 

    Health Care REIT, Inc.

    One SeaGate, Suite 1500

    Toledo, Ohio 43604

    Attention: General Counsel

    Facsimile No.:
    (419) 247-2826

 

    with copies (which shall not constitute notice) to:

 

    Shumaker, Loop & Kendrick, LLP

    North Courthouse Square

    1000 Jackson

    Toledo, Ohio
    42624-1573

    Attention: Mary Ellen Pisanelli, Esq.

 

    and

 

    Sidley Austin LLP

    One South Dearborn

    Chicago, Illinois 60603

    Attention: David J. Zampa, Esq.

    

    3

 

 

    (b) if to the Shareholder to:

 

    Windrose Medical Properties Trust

    3502 Woodview Trace

    Suite 210

    Indianapolis, IN 46268

    Attention: Fred S. Klipsch

 

    with a copy (which shall not constitute notice) to:

 

    Hunton & Williams LLP

    Riverfront Plaza, East Tower

    951 East Byrd Street

    Richmond, Virginia 23219

    Attention: David C. Wright, Esq.

 

    13. Counterparts.   For the
    convenience of the parties, this Agreement may be executed in
    counterparts, each of which shall be deemed an original, but all
    of which together shall constitute one and the same instrument.

 

    14. No Limitation on Actions of the Shareholder as
    Director or Officer.   Notwithstanding
    anything to the contrary in this Agreement, nothing in this
    Agreement is intended or shall be construed to require the
    Shareholder to take or in any way limit any action that the
    Shareholder may take to discharge the Shareholder’s
    fiduciary duties as a director or officer of the Company,
    including but not limited to the right to vote for or support a
    Superior Acquisition Proposal, the termination of the Merger
    Agreement or any other action, in each case in accordance with
    the terms of the Merger Agreement.

    

    4

 

    IN WITNESS WHEREOF, the parties have executed this Agreement as
    of the date first written above.

 

    /s/  Fred
    S. Klipsch

    Name: Fred S. Klipsch

 

    Number of Company Common Shares

    owned on the date hereof: 74,301

 

    Number of Company Common Shares held

    subject to restriction or forfeiture: 35,400

 

    Number of Company OP Units

    owned on the date hereof: 143,414

 

    Accepted and Agreed to

    as of the date set forth above:

 

    HEALTH CARE REIT, INC.

 

    /s/  George
    L. Chapman

    Name: George L. Chapman

			
	    Title: 
	
    Chairman and Chief Executive Officer
	 

    

    5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00111-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00111-of-00352.parquet"}]]